disease drug
Applied Therapeutics Undergoes Leadership Changes Amid FDA Rejection and Regulatory Challenges
Applied Therapeutics, leadership changes, FDA rejection, rare disease drug, govorestat, regulatory challenges
Actionable Insights Powered by AI
Applied Therapeutics, leadership changes, FDA rejection, rare disease drug, govorestat, regulatory challenges